Lowest Price Guaranteed
Pages
198
Last Updated
September 2025
View Count
11379
SECTION I: REPORT OVERVIEW
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
SECTION II: QUALITATIVE INSIGHTS
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of AI in Digital Genome
6.2.1. Key Characteristics of AI in Digital Genome
6.2.2. Key Applications of the AI in Digital Genome
6.2.3. Challenges Associated with AI in Digital Genome
6.3. Future Perspective
7. REGULATORY SCENARIO
SECTION III: MARKET OVERVIEW
8. COMPREHENSIVE DATABASE OF LEADING PLAYERS
9. COMPETITIVE LANDSCAPE
9.1. Chapter Overview
9.2. AI in Digital Genome: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters
9.2.4. AI in Digital Genome Market: Overall Market Landscape
9.2.4.1. Analysis by Offering Type
9.2.4.2. Analysis by Technology Type
9.2.4.3. Analysis by Functionality Type
9.2.4.4. Analysis by Application Area
9.2.4.5. Analysis by End User
10. PORTER'S FIVE FORECES ANALYSIS
11. COMPANY COMPETITIVENESS ANALYSIS
12. STARTUP ECOSYSTEM IN THE AI IN DIGITAL GENOME MARKET
12.1. AI in Digital Genome: Market Landscape of Startups
12.1.1. Analysis by Year of Establishment
12.1.2. Analysis by Company Size
12.1.3. Analysis by Company Size and Year of Establishment
12.1.4. Analysis by Location of Headquarters
12.1.5. Analysis by Company Size and Location of Headquarters
12.1.6. Analysis by Ownership Structure
12.2. Key Findings
SECTION IV: COMPANY PROFILES
13. COMPANY PROFILES
13.1. Chapter Overview
13.2. BenevolentAl (UK)
13.2.1. Company Overview
13.2.2. Company Mission
13.2.3. Company Footprint
13.2.4. Management Team
13.2.5. Contact Details
13.2.6. Financial Performance
13.2.7. Operating Business Segments
13.2.8. Service Portfolio (project specific)
13.2.9. MOAT Analysis
13.2.10. Recent Developments and Future Outlook
* similar detail is presented for other below mentioned companies based on information in the public domain
13.3. Deep Genomics (Canada)
13.4. Fabric Genomics (US)
13.5. IBM (US)
13.6. Microsoft (US)
13.7. MolecularMatch (US)
13.8. NVIDIA (US)
13.9. PrecisionLife (UK)
13.10. SOPHIA GENETICS (Switzerland)
13.11. Verge Genomics (US)
SECTION V: MARKET TRENDS
14. PARTNERSHIPS AND COLLABORATIONS
14.1. Chapter Overview
14.2. Partnership Models
14.3. AI in Digital Genome: Partnerships and Collaborations
14.3.1. Analysis by Year of Partnership
14.3.2. Analysis by Type of Partnership
14.3.3. Analysis by Year and Type of Partnership
14.3.4. Analysis by Type of Partner
14.3.5. Analysis by Location of Headquarters of Partner
14.3.6. Analysis by Type of Partnership and Location of Headquarters of Partner
14.3.7. Most Active Players: Analysis by Number of Partnerships
14.3.8. Regional Analysis
SECTION VI: MARKET OPPORTUNITY ANALYSIS
15. GLOBAL AI IN DIGITAL GENOME MARKET
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Trends Disruption Impacting Market
15.4. Demand Side Trends
15.5. Supply Side Trends
15.6. Global AI in Digital Genome Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7. Multivariate Scenario Analysis
15.7.1. Conservative Scenario
15.7.2. Optimistic Scenario
15.8. Investment Feasibility Index
15.9. Key Market Segmentations
16. MARKET OPPORTUNITIES BASED ON TYPE OF OFFERING
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. AI in Digital Genome Market for Software: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.7. AI in Digital Genome Market for Services: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.8. Data Triangulation and Validation
16.8.1. Secondary Sources
16.8.2. Primary Sources
16.8.3. Statistical Modeling
17. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. AI in Digital Genome Market for Machine Learning: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. AI in Digital Genome Market for Computer Vision: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.8. Data Triangulation and Validation
17.8.1. Secondary Sources
17.8.2. Primary Sources
17.8.3. Statistical Modeling
18. MARKET OPPORTUNITIES BASED ON TYPE OF FUNCTIONALITY
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. AI in Digital Genome Market for Genome Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.7. AI in Digital Genome Market for Gene Editing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.8. Data Triangulation and Validation
18.8.1. Secondary Sources
18.8.2. Primary Sources
18.8.3. Statistical Modeling
19. MARKET OPPORTUNITIES BASED ON APPLICATION AREA
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. AI in Digital Genome Market for Diagnosis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7. AI in Digital Genome Market for Drug Discovery and Development: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.8. AI in Digital Genome Market for Precision Medicine: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.9. AI in Digital Genome Market for Agriculture & Animal Research: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.10. AI in Digital Genome Market for Other Applications: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.11. Data Triangulation and Validation
19.11.1. Secondary Sources
19.11.2. Primary Sources
19.11.3. Statistical Modeling
20. MARKET OPPORTUNITIES BASED ON END USER
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. AI in Digital Genome Market for Pharmaceutical and Biotechnology Companies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.7. AI in Digital Genome Market for Research Organizations: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.8. AI in Digital Genome Market for Ambulatory Surgery Centers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.9. AI in Digital Genome Market for Other End Users: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.10. Data Triangulation and Validation
20.10.1. Secondary Sources
20.10.2. Primary Sources
20.10.3. Statistical Modeling
21. MARKET OPPORTUNITIES FOR AI IN DIGITAL GENOME IN NORTH AMERICA
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix
21.6. AI in Digital Genome Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.1. AI in Digital Genome Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.2. AI in Digital Genome Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.3. AI in Digital Genome Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.7. Data Triangulation and Validation
22. MARKET OPPORTUNITIES FOR AI IN DIGITAL GENOME IN EUROPE
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix
22.6. AI in Digital Genome Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.1. AI in Digital Genome Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.2. AI in Digital Genome Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.3. AI in Digital Genome Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.4. AI in Digital Genome Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.5. AI in Digital Genome Market in The UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.6. AI in Digital Genome Market in Rest of the Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.7. Data Triangulation and Validation
23. MARKET OPPORTUNITIES FOR AI IN DIGITAL GENOME IN ASIA-PACIFIC
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix
23.6. AI in Digital Genome Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.1. AI in Digital Genome Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.2. AI in Digital Genome Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.3. AI in Digital Genome Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.4. AI in Digital Genome Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.5. AI in Digital Genome Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.7. Data Triangulation and Validation
24. MARKET OPPORTUNITIES FOR AI IN DIGITAL GENOME IN MIDDLE EAST & AFRICA (MEA)
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Revenue Shift Analysis
24.4. Market Movement Analysis
24.5. Penetration-Growth (P-G) Matrix
24.6. AI in Digital Genome Market in Middle East and Africa (MEA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.1. AI in Digital Genome Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.2. AI in Digital Genome Market in Iran: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.3. AI in Digital Genome Market in Iraq: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.4. AI in Digital Genome Market in Israel: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.5. AI in Digital Genome Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.6. AI in Digital Genome Market in United Araba Emirates: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.7. Data Triangulation and Validation
25. MARKET OPPORTUNITIES FOR AI IN DIGITAL GENOME IN LATIN AMERICA
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Revenue Shift Analysis
25.4. Market Movement Analysis
25.5. Penetration-Growth (P-G) Matrix
25.6. AI in Digital Genome Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.1. AI in Digital Genome Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.2. AI in Digital Genome Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.7. Data Triangulation and Validation
26. ADJACENT MARKET ANALYSIS
SECTION VII: STRATEGIC TOOLS
27. KEY WINNING STRATEGIES
28. VALUE CHAIN ANALYSIS
29. ROOTS STRATEGIC RECOMMENDATIONS
SECTION VIII: OTHER EXCLUSIVE INSIGHTS
30. INSIGHTS FROM PRIMARY RESEARCH
31. REPORT CONCLUSION
SECTION IX: APPENDIX
32. TABULATED DATA
33. LIST OF COMPANIES AND ORGANIZATIONS
34. CUSTOMIZATION OPPORTUNITIES
35. ROOTS SUBSCRIPTION SERVICES
36. AUTHOR DETAILS